CDKN2A and glioblastoma: To test this hypothesis, we exogenously expressed IDH1-R132H to induce a G-CIMP+ state [7] in the human U87MG glioblastoma line as well as an Ink4a-Arf−/− genetically engineered murine model (GEMM) derived glioblastoma line [36].